Filtering by:
Breast CancerNot All Black Women in the United States Have the Same Level of Risk for Triple-Negative Breast Cancer
We’ve known for a while that triple-negative breast cancer is more common in black women in the United States, compared to other groups. The news is the prevalence varies significantly depending on where these women were born. American Cancer Society (ACS) researchers found that among black women, those born in the US and Western Africa were diagnosed more often with triple-negative breast cancer than women born in East Africa. The authors published their findings in Cancer, an ACS peer-reviewed journal.
Breast Cancer Survivor Reaches Marathon Goals
Breast cancer survivor Fran Boyd is one of only 6,000 or so people worldwide to complete the World Majors, 6 of the biggest and most famous marathons.
FDA Approves First PI3K Inhibitor for Breast Cancer
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.
What to Know About Getting a Mammogram
Getting regular mammograms can help women find breast cancer early. Whether this is your first screening or your 10th, knowing what to expect can help you navigate the process more smoothly.
Soy and Cancer Risk: Our Expert’s Advice
Some studies have shown that eating soy foods such as tofu may lower the risk of some cancers. But our nutrition expert says taking soy supplements is not a good idea.
Breast Cancer Patients Make Recommendations to Address High Health Care Costs
Breast cancer patients, especially if they have lymphedema, face an especially high cost of health care according to authors of a paper published March 6, 2019 in Cancer, a peer-reviewed medical journal of the American Cancer Society.
FDA Approves Immunotherapy for Breast Cancer
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer.
Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
